HCWB — HCW BIOLOGICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | 55.0% | -6298.4% | — | — | — | — |
Net margin trend
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 12 SEC-registered investment managers reported holding HCWB (HCW BIOLOGICS INC) in their latest 13F filings, with a combined reported value of $272.89K across 159.59K shares. That is +36.9% by share count (+31.92K shares) versus the previous quarter, while reported value moved -53.1%. Ownership is concentrated: the five largest holders account for 93.3% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 3 opened new positions, 4 added to existing stakes, 2 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of HCW BIOLOGICS INC (HCWB) include ARMISTICE CAPITAL, LLC, HighTower Advisors, LLC, Avantax Planning Partners, Inc., ranked by reported 13F value among the 40 institutional holders on this page.
HCWB is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 12 | 159.59K | $272.89K | +36.9% |
| Q2 2026 | 12 | 103.50K | $515.67K | -71.8% |
| Q1 2026 | 14 | 449.85K | $160.83K | +101.2% |
| Q4 2025 | 13 | 401.65K | $389.86K | +12.4% |
| Q3 2025 | 9 | 40.04K | $148.14K | +10.9% |
| Q2 2025 | 8 | 21.57K | $85.52K | -77.2% |
| Q1 2025 | 15 | 1.16M | $325.98K | +31.7% |
| Q4 2024 | 18 | 3.13M | $1.40M | -6.1% |
Over the 8 quarters shown, institutional share counts decreased 95% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2026 (+101.2%).
Top Institutional Holders (Q3 2026) — 12 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 46.02K | $78.70K | 0.00% | Reduce | |
| 44.82K | $76.64K | 0.00% | Add | |
| 29.02K | $49.62K | 0.00% | New | |
| 17.27K | $29.53K | 0.00% | Add | |
| 11.74K | $20.08K | 0.00% | New | |
| 6.51K | $11.13K | 0.00% | Hold | |
| 2.00K | $3.43K | 0.00% | Hold | |
| 1.67K | $2.85K | 0.00% | Hold | |
| 514 | $879 | 0.00% | New | |
| 6 | $11 | 0.00% | Add | |
| 5 | $9 | 0.00% | Add | |
| 4 | $7 | 0.00% | Reduce |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 12 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 52.14K | $260.17K | 0.00% | Add | |
| 19.94K | $99.51K | 0.00% | Reduce | |
| 13.58K | $67.00K | 0.00% | Reduce | |
| 6.51K | $32.48K | 0.00% | Add | |
| 4.12K | $20.54K | 0.00% | Reduce | |
| 3.34K | $16.66K | 0.01% | New | |
| 2.00K | $9.99K | 0.00% | Reduce | |
| 1.67K | $8.32K | 0.00% | Reduce | |
| 191 | $953 | 0.00% | New | |
| 4 | $20 | 0.00% | Reduce | |
| 11 | $10 | 0.00% | New | |
| 1 | $5 | 0.00% | Reduce |
Q1 2026 — 14 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 266.39K | $95.00K | 0.00% | New | |
| 47.81K | $17.00K | 0.00% | New | |
| 35.89K | $12.92K | 0.00% | Add | |
| 26.08K | $9.39K | 0.00% | Add | |
| 14.84K | $5.34K | 0.00% | Add | |
| 14.13K | $5.09K | 0.00% | New | |
| 12.02K | $4.33K | 0.00% | New | |
| 10.53K | $3.79K | 0.00% | Add | |
| 10.00K | $3.60K | 0.00% | Hold | |
| 9.22K | $3.32K | 0.00% | Add | |
| 1.90K | $685 | 0.00% | New | |
| 1.00K | $360 | 0.00% | Hold | |
| 26 | $9 | 0.00% | Hold | |
| 2 | $1 | 0.00% | New |
Q4 2025 — 13 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 300.18K | $291.36K | 0.00% | New | |
| 22.16K | $21.51K | 0.00% | New | |
| 20.07K | $19.48K | 0.00% | New | |
| 15.43K | $14.98K | 0.00% | Hold | |
| 14.04K | $13.62K | 0.00% | Add | |
| 12.50K | $12.13K | 0.00% | New | |
| 10.00K | $9.71K | 0.00% | Hold | |
| 4.50K | $4.37K | 0.00% | Add | |
| 1.74K | $1.69K | 0.00% | New | |
| 1.00K | $971 | 0.00% | Reduce | |
| 26 | $25 | 0.00% | Hold | |
| 11 | $11 | 0.00% | Add | |
| 1 | $1 | 0.00% | Reduce |
Q3 2025 — 9 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 15.43K | $57.08K | 0.00% | New | |
| 11.00K | $40.71K | 0.00% | New | |
| 10.00K | $37.00K | 0.00% | Hold | |
| 1.70K | $6.29K | 0.00% | Hold | |
| 1.56K | $5.78K | 0.00% | Add | |
| 311 | $1.15K | 0.00% | New | |
| 26 | $96 | 0.00% | Hold | |
| 10 | $37 | 0.00% | Hold | |
| 1 | $4 | 0.00% | Reduce |
Q2 2025 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 10.00K | $39.65K | 0.01% | New | |
| 9.52K | $37.74K | 0.00% | New | |
| 1.70K | $6.74K | 0.00% | New | |
| 250 | $991 | 0.00% | Add | |
| 58 | $230 | 0.00% | New | |
| 26 | $103 | 0.00% | Reduce | |
| 10 | $40 | 0.00% | Reduce | |
| 6 | $24 | 0.00% | New |
New Positions (Q3 2026)
- STATE STREET CORP 29.02K sh · $49.62K
- Geode Capital Management 11.74K sh · $20.08K
- Citigroup Inc 514 sh · $879
Fully Exited (vs previous quarter)
- HRT FINANCIAL LP sold 13.58K sh · $67.00K
- Connective Capital Management, LLC sold 3.34K sh · $16.66K
- BARCLAYS PLC sold 191 sh · $953
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JANE STREET GROUP, LLC | 46.02K | 52.14K | 14.13K | — | — | — | — | — | — | 24.14K | 17.25K | — | — | — | — | — | — | — | — | — |
| Citadel Advisors | 44.82K | 19.94K | 26.08K | 22.16K | — | — | — | — | — | 13.88K | — | 10.35K | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 29.02K | — | — | — | — | — | 21.45K | 21.45K | 21.45K | 21.45K | 21.45K | 21.45K | 21.45K | — | — | — | — | — | — | — |
| Tower Research Capital LLC (TRC) | 17.27K | 4.12K | 14.84K | 4.50K | 1.56K | 250 | 32 | 1.79K | 5.88K | 6.21K | 4.94K | 5.67K | 4.66K | — | — | — | — | — | — | — |
| Geode Capital Management | 11.74K | — | 35.89K | 14.04K | 11.00K | — | 236.97K | 181.96K | 183.26K | 170.38K | 174.28K | 134.44K | 132.50K | 131.03K | 131.03K | 131.03K | 131.31K | 55.42K | 53.17K | 42.48K |
| VANGUARD FIDUCIARY TRUST CO | 6.51K | 6.51K | 1.90K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.00K | 2.00K | 12.02K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Golden State Wealth Management, LLC | 1.67K | 1.67K | 10.00K | 10.00K | 10.00K | 10.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Citigroup Inc | 514 | — | 10.53K | 1 | 311 | — | 14.05K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 6 | 1 | 9.22K | 1.74K | — | 9.52K | — | — | 4.83K | 4.29K | 605 | 635 | 212 | — | 16 | 381 | — | 2.06K | 1.71K | — |
| OSAIC HOLDINGS, INC. | 5 | 4 | 26 | 26 | 26 | 26 | 1.01K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Caitong International Asset Management Co., Ltd | 4 | 11 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ARMISTICE CAPITAL, LLC | — | — | — | 300.18K | — | — | — | 2.02M | — | — | — | — | — | — | — | — | — | — | — | — |
| HighTower Advisors, LLC | — | — | — | — | — | — | — | 180.81K | 180.81K | 180.81K | 179.81K | 179.81K | 354.87K | — | — | — | — | — | — | — |
| Vanguard Group | — | — | — | 15.43K | 15.43K | — | 243.16K | 37.68K | 37.68K | 37.68K | 37.65K | 205.14K | 204.62K | 187.09K | 181.87K | 181.87K | 95.39K | 86.90K | 82.52K | 82.52K |
| Avantax Planning Partners, Inc. | — | — | — | — | — | — | 279.54K | 279.54K | 279.54K | 279.54K | 179.78K | 179.54K | — | — | — | — | — | — | — | — |
| Cresset Asset Management, LLC | — | — | — | — | — | — | 131.99K | 131.99K | 131.99K | 131.99K | 131.99K | 131.99K | 131.99K | — | — | — | — | — | — | — |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | — | — | — | — | — | — | — | 34.70K | 84.70K | 84.70K | 84.70K | 84.70K | 82.60K | — | — | — | — | — | — | — |
| Pullen Investment Management, LLC | — | — | — | — | — | — | 75.12K | 75.12K | 75.12K | 85.12K | 85.12K | — | — | — | — | — | — | — | — | — |
| HRT FINANCIAL LP | — | 13.58K | 266.39K | — | — | — | — | — | 46.50K | 66.66K | 73.11K | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold HCWB?
As of 2026-Q3, 12 institutional funds reported holding HCWB (HCW BIOLOGICS INC) in SEC 13F filings, with a combined reported value of $272.89K.
How many shares of HCWB do institutions own?
13F filers reported 159.59K shares of HCWB, worth $272.89K in aggregate at the end of 2026-Q3.
Is institutional ownership of HCWB rising or falling?
Share counts moved +36.9% versus the prior quarter — accumulation.
Who are the top institutional holders of HCWB?
The largest 13F holders are ARMISTICE CAPITAL, LLC, HighTower Advisors, LLC, Avantax Planning Partners, Inc., JANE STREET GROUP, LLC, Citadel Advisors; the top 25 are ranked at the top of this page.
Who are the major shareholders of HCW BIOLOGICS INC?
The major shareholders of HCW BIOLOGICS INC (HCWB) by reported 13F value are ARMISTICE CAPITAL, LLC, HighTower Advisors, LLC, Avantax Planning Partners, Inc., JANE STREET GROUP, LLC, Citadel Advisors, among 40 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.